Why the study?
HCM is an inherited cardiac disorder with MYBPC3 and PRKAG2 as known causal genes, requiring cellular models to investigate variant-specific pathological mechanisms.
Population
Two HCM patients carrying heterozygous mutations in MYBPC3 (c.459delC) and PRKAG2 (c.1703C > T)
Design
In vitro stem cell generation study
Authors
Loading...
Patient-specific iPSC lines enable in vitro HCM mechanism studies; leaves open clinical translation pending validation.
The successful generation of these patient-specific iPSC lines provides a valuable in vitro model for studying the pathological mechanisms of hypertrophic cardiomyopathy associated with MYBPC3 and PRKAG2 variants.
Manhas et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: